Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD8-Positive T-Lymphocytes | 10 | 2024 | 558 | 2.370 |
Why?
|
| Immune Tolerance | 4 | 2023 | 337 | 1.640 |
Why?
|
| Antigens | 2 | 2023 | 228 | 1.560 |
Why?
|
| Acetylgalactosamine | 2 | 2021 | 8 | 0.970 |
Why?
|
| Hepatocytes | 2 | 2021 | 127 | 0.830 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2023 | 159 | 0.830 |
Why?
|
| Cross-Priming | 2 | 2021 | 48 | 0.820 |
Why?
|
| Cell Engineering | 1 | 2020 | 5 | 0.760 |
Why?
|
| Skin | 1 | 2023 | 554 | 0.720 |
Why?
|
| Antigens, Neoplasm | 1 | 2020 | 325 | 0.650 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2019 | 295 | 0.570 |
Why?
|
| Melanoma, Experimental | 2 | 2018 | 103 | 0.560 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2015 | 9 | 0.550 |
Why?
|
| Cancer Vaccines | 1 | 2015 | 156 | 0.490 |
Why?
|
| Dendritic Cells | 2 | 2018 | 425 | 0.460 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2021 | 425 | 0.350 |
Why?
|
| Antigen Presentation | 2 | 2021 | 209 | 0.330 |
Why?
|
| Ovalbumin | 2 | 2021 | 109 | 0.330 |
Why?
|
| Mice, Inbred C57BL | 6 | 2021 | 3095 | 0.320 |
Why?
|
| Mice | 8 | 2024 | 11356 | 0.320 |
Why?
|
| Animals | 10 | 2024 | 26590 | 0.260 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 1540 | 0.250 |
Why?
|
| Norovirus | 1 | 2024 | 13 | 0.240 |
Why?
|
| Neoplasms | 1 | 2019 | 2898 | 0.240 |
Why?
|
| Lichen Planus | 1 | 2023 | 10 | 0.230 |
Why?
|
| Adoptive Transfer | 2 | 2021 | 168 | 0.230 |
Why?
|
| Epidermis | 1 | 2023 | 100 | 0.220 |
Why?
|
| Interleukins | 1 | 2021 | 134 | 0.200 |
Why?
|
| Vesicular Transport Proteins | 1 | 2021 | 63 | 0.190 |
Why?
|
| Solubility | 1 | 2021 | 177 | 0.190 |
Why?
|
| Cells, Cultured | 3 | 2022 | 2819 | 0.190 |
Why?
|
| Skin Transplantation | 1 | 2021 | 172 | 0.180 |
Why?
|
| Organ Specificity | 1 | 2020 | 258 | 0.180 |
Why?
|
| Acetylglucosamine | 1 | 2019 | 17 | 0.180 |
Why?
|
| Mice, Knockout | 2 | 2021 | 1924 | 0.180 |
Why?
|
| B-Lymphocytes | 2 | 2021 | 724 | 0.180 |
Why?
|
| Biopsy | 1 | 2023 | 1163 | 0.170 |
Why?
|
| RNA Splicing | 1 | 2020 | 142 | 0.170 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 2262 | 0.170 |
Why?
|
| Interleukin-10 | 1 | 2019 | 149 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 1 | 2020 | 1041 | 0.160 |
Why?
|
| Antibody Affinity | 1 | 2018 | 38 | 0.160 |
Why?
|
| CD40 Antigens | 1 | 2018 | 43 | 0.160 |
Why?
|
| Lymph Nodes | 1 | 2021 | 533 | 0.150 |
Why?
|
| Gene Expression Profiling | 1 | 2023 | 1384 | 0.150 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 232 | 0.150 |
Why?
|
| Adaptation, Physiological | 1 | 2019 | 306 | 0.140 |
Why?
|
| Exosomes | 1 | 2015 | 50 | 0.130 |
Why?
|
| Immunotherapy | 2 | 2021 | 629 | 0.130 |
Why?
|
| Lipopolysaccharides | 1 | 2015 | 286 | 0.120 |
Why?
|
| Adenocarcinoma | 1 | 2021 | 1169 | 0.120 |
Why?
|
| Killer Cells, Natural | 1 | 2015 | 267 | 0.120 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2019 | 568 | 0.120 |
Why?
|
| Humans | 9 | 2024 | 86678 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 1 | 2018 | 1376 | 0.100 |
Why?
|
| Lentivirus | 1 | 2011 | 36 | 0.100 |
Why?
|
| Integrases | 1 | 2011 | 59 | 0.100 |
Why?
|
| Mutagenesis, Insertional | 1 | 2011 | 111 | 0.100 |
Why?
|
| Gene Transfer Techniques | 1 | 2011 | 152 | 0.100 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2011 | 279 | 0.100 |
Why?
|
| Epitopes | 1 | 2011 | 255 | 0.090 |
Why?
|
| Genetic Vectors | 1 | 2011 | 439 | 0.090 |
Why?
|
| Female | 5 | 2021 | 44550 | 0.090 |
Why?
|
| Immune Privilege | 1 | 2024 | 1 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 2426 | 0.060 |
Why?
|
| T-Lymphocytes | 2 | 2019 | 1195 | 0.050 |
Why?
|
| Intestines | 1 | 2024 | 411 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 371 | 0.050 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 187 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2019 | 252 | 0.040 |
Why?
|
| Autoantigens | 1 | 2019 | 127 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2021 | 728 | 0.040 |
Why?
|
| Spleen | 1 | 2019 | 430 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 418 | 0.040 |
Why?
|
| Placenta Growth Factor | 1 | 2018 | 70 | 0.040 |
Why?
|
| Immunity | 1 | 2018 | 136 | 0.040 |
Why?
|
| beta Catenin | 1 | 2018 | 251 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2018 | 790 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2022 | 1458 | 0.030 |
Why?
|
| Peptides | 1 | 2018 | 639 | 0.030 |
Why?
|
| Liver | 1 | 2019 | 1230 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 2231 | 0.030 |
Why?
|
| Receptors, CCR5 | 1 | 2011 | 17 | 0.030 |
Why?
|
| Dependovirus | 1 | 2011 | 33 | 0.030 |
Why?
|
| Virus Integration | 1 | 2011 | 16 | 0.030 |
Why?
|
| Risk | 1 | 2011 | 674 | 0.020 |
Why?
|
| DNA Damage | 1 | 2011 | 366 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2011 | 1047 | 0.020 |
Why?
|
| Male | 1 | 2021 | 40988 | 0.010 |
Why?
|